Combination therapies using immuno-dash inhibitors and PGE2 antagonists
Abstract:
Disclosed are combination therapies including administration of I-DASH inhibitors and PGE2 antagonists, and the use of such therapies in the treatment of cell proliferative diseases.
Information query
Patent Agency Ranking
0/0